FDA Inspection 1155278 — Coty US LLC

Coty US LLC — FEI 1025346

The FDA completed an inspection of Coty US LLC on Oct 27, 2021 in Sanford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 9 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 27, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Sanford, NC (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
126321 CFR 211.68(b)Computer control of master formula records
176721 CFR 211.137(a)Expiration date lacking
188321 CFR 211.165(a)Testing and release for distribution
197521 CFR 211.182Written records kept in individual logs
204421 CFR 211.196Distribution Record Requirements
356721 CFR 211.84(d)(2)Component identification test
358521 CFR 211.110(a)Control procedures to monitor and validate performance

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.